Correction: A Cancer Specific Cell-Penetrating Peptide, BR2, for the Efficient Delivery of an scFv into Cancer Cells

Correction: A Cancer Specific Cell-Penetrating Peptide, BR2, for the Efficient Delivery of an scFv into Cancer Cells

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829981/?tool=EBI

Similar Items

Correction: A Cancer Specific Cell-Penetrating Peptide, BR2, for the Efficient Delivery of an scFv into Cancer Cells.
by: Ki Jung Lim, et al.
Published: (2013-01-01)

A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells.
by: Ki Jung Lim, et al.
Published: (2013-01-01)

Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
by: Chung Hyo Kang, et al.
Published: (2020-12-01)

INCREASING OF THE EXPRESSION OF RECOMBINANT scFv-ANTIBODIES EFFICIENCY
by: O.V. Galkin, et al.
Published: (2017-10-01)

BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor.
by: Ting Yu, et al.
Published: (2022-01-01)

BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor
by: Ting Yu, et al.
Published: (2022-01-01)

The effects of N-terminal insertion into VSV-G of an scFv peptide
by: Piechaczyk Marc, et al.
Published: (2006-09-01)

Cell Penetrable Human scFv Specific to Middle Domain of Matrix Protein-1 Protects Mice from Lethal Influenza
by: Fonthip Dong-din-on, et al.
Published: (2015-01-01)

310 Targeted delivery of a VEGF-blocking scFv to enhance CAR-T cell potency
by: Marcela Maus, et al.
Published: (2023-11-01)

Augmenting the Effectiveness of CAR-T Cells by Enhanced Self-Delivery of PD-1-Neutralizing scFv
by: Yu Ping, et al.
Published: (2020-08-01)

scFv biofunctionalized nanoparticles to effective and safe targeting of CEA-expressing colorectal cancer cells
by: Maria José Silveira, et al.
Published: (2023-10-01)

Self-assembling complexes of quantum dots and scFv antibodies for cancer cell targeting and imaging.
by: Tatiana A Zdobnova, et al.
Published: (2012-01-01)

“Stapling” scFv for multispecific biotherapeutics of superior properties
by: Lauren E. Boucher, et al.
Published: (2023-12-01)

Species-Dependent Functionality of the Human Cytolytic Fusion Proteins Granzyme B-H22(scFv) and H22(scFv)-Angiogenin in Macrophages
by: Theo Thepen, et al.
Published: (2013-01-01)

Self-delivery of TIGIT-blocking scFv enhances CAR-T immunotherapy in solid tumors
by: Fan Yang, et al.
Published: (2023-06-01)

Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer
by: Jian Chen, et al.
Published: (2023-08-01)

Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy
by: Zhaohuan Li, et al.
Published: (2021-12-01)

Baculovirus display of single chain antibody (scFv) using a novel signal peptide
by: Gonzalez Gaëlle, et al.
Published: (2010-11-01)

Quantum Dot- Conjugated Anti-GRP78 scFv Inhibits Cancer Growth in Mice
by: David Hornby, et al.
Published: (2012-01-01)

Integrating scFv into xMAP Assays for the Detection of Marine Toxins
by: Lisa C. Shriver-Lake, et al.
Published: (2016-11-01)

Generation of recombinant scFv antibody against Ochratoxin A (OTA)
by: Ranya Pranomphon, et al.
Published: (2018-02-01)

Production of a germline-humanized cetuximab scFv and evaluation of its activity in recognizing EGFR- overexpressing cancer cells
by: Arsham Banisadr, et al.
Published: (2018-04-01)

Radiosensitization and growth inhibition of cancer cells mediated by an scFv antibody gene against DNA-PKcs in vitro and in vivo
by: Du Li, et al.
Published: (2010-08-01)

Development and molecular analyses of Xanthomonas pthA specific scFv recombinant monoclonal antibodies
by: Hamideh Raeisi, et al.
Published: (2019-08-01)

Broad specificity of immune helminth scFv library to identify monoclonal antibodies targeting Strongyloides
by: Anizah Rahumatullah, et al.
Published: (2021-01-01)

Recombinant norovirus-specific scFv inhibit virus-like particle binding to cellular ligands
by: Hardy Michele E, et al.
Published: (2008-01-01)

Expression, purification and characterization of α-synuclein fibrillar specific scFv from inclusion bodies.
by: Vijay Gupta, et al.
Published: (2020-01-01)

Enhanced fluorescent imaging of proteins in live yeast cells using fluorescently labeled scFv
by: Ioannis Tsirkas, et al.
Published: (2023-06-01)

Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma
by: Chengcheng Zhang, et al.
Published: (2023-05-01)

Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer
by: Cynthia Rodríguez-Nava, et al.
Published: (2023-06-01)

Production of a functional anti-scorpion hemocyanin scFv in Escherichia coli.
by: Billiald, P, et al.
Published: (1995)

Development and in vitro characterization of a humanized scFv against fungal infections
by: Tomas Di Mambro, et al.
Published: (2022-01-01)

Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes
by: Christophe Alric, et al.
Published: (2018-02-01)

Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E.
by: Sebastian Miethe, et al.
Published: (2015-01-01)

Toward low-cost affinity reagents: lyophilized yeast-scFv probes specific for pathogen antigens.
by: Sean A Gray, et al.
Published: (2012-01-01)

Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies
by: Irina V. Kholodenko, et al.
Published: (2019-10-01)

Identification of a GTP-bound Rho specific scFv molecular sensor by phage display selection
by: Chinestra Patrick, et al.
Published: (2008-03-01)

Correction to: RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480
by: Chen-Chen Huang, et al.
Published: (2021-04-01)

Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC
by: Micaela Harrasser, et al.
Published: (2022-06-01)

Relative Contribution of Framework and CDR Regions in Antibody Variable Domains to Multimerisation of Fv- and scFv-Containing Bispecific Antibodies
by: Pallavi Bhatta, et al.
Published: (2018-08-01)